From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

TERN
premium content

New Magnus Opus: You TERN If You Want To…..

AIM-listed jam-tomorrow Internet of Things investment company Tern plc (TERN) is in real trouble. It is short of cash, can’t issue shares, its investees continue to burn cash meaning cash-calls imminently and Tern’s “up to….” £3 million lending facility is also in trouble due to the company’s inability to issue shares. It is a perfect storm which is set to get worse. Here, in detail, are the reasons this bulletin board darling is a slam-dunk sell as it struggles with four major financing issues.
RYA

Luck of the Irish should Ensure this Budget Airline Will Continue to Fly High.

Hello Share Takers. They tell me that most airlines have upped their prices to make up for the bad time they had during Covid. Well, that may be so, but fares were ridiculously cheap before and are still tempting today. For example, I plan to fly to New York in December and it will cost me £400 return.
Bearcast
premium content

Tom Winnifrith Bearcast: my gold stocks have 3 years to deliver but some are not in danger

In today's bearcast I discuss what the BBC won't be, yet more rain here in Greece. Then it is onto gold and my boredom. I discuss Ariana (AAU), Centamin (CEY), Kefi Gold & Copper (KEFI) - where I have swapped emails with 'arry this weekend -, Amaroq (AMRQ) and Jubilee Metals (JLP).And yes there are now just 4 of 100 seats left for ShareStock. Ticket emails will be going out within 24 hours on logistics to those who have booked. If you have not, those 4 go on a first come first served basis HERE.

Professor
premium content

Sunday Long Reads: Trans Activism, Death on K2, Gen Z loves CDs, Runaway Train, 90s Boxing

Sunday is a good time to sit back, read, and forget about shares. Put the kettle on, find a comfy chair. You have the time, don't you?

Wolf-of-Wall-Street

Visual Aid: The 50 Most Valuable Companies in the World in 2023

In this graphic, we present a treemap chart that visualises the world’s top 50 publicly-traded companies by market cap, using data as of Aug. 16, 2023. Painfully, the highest-ranked UK company is AstraZeneca, at number 45. The highest-ranked EU company is France’s LVMH, at number 15. As usual, courtesy of Visual Capitalist

Gold
premium content

The View From The Montana Log-Cabin As Gold Bounces; Fed In A Jackson’s Hole

Jordan Roy-Byrne of TheDailyGold.com, our favourite technical analyst, has been saying for a few days that Gold was due a bounce. It duly did – on pretty awful US PMI data on Wednesday – and closed the week back over $1900 at $1915, compared to the prior week’s $1890. The miners followed suit – has a low been put in yet?
Quiz
premium content

The ShareProphets Sunday Pub Quiz #203

It's time for the ShareProphets Sunday Pub Quiz.. There are no prizes! And remember, no Googling!


Top-10

Notes from Underground – Most read articles for the week ending 26 August

Another week gone and here are the most read and most listened-to articles and Bearcasts on ShareProphets over the past seven days. The most read non-Quiz, non-Tom article last week is by Lucien Miers, Crunch Time for the Tingo Three, at No 2 or No 7 including Bearcasts.

Bearcast
premium content

Tom Winnifrith Bearcast: is Malcolm mad and will the FCA fail a number of acid tests flagged up today?

I start with a report on extreme Greek Weather experienced today as I reported HERE. Then onto Malcolm vs Nigel and then onto a string of exposes on this website today. Will the FCA do anything? Finally there are now just five tickets left for ShareStock on 23rd September book now to get one of them HERE.

ROQ
premium content

Concerns regarding Roquefort Therapeutics and Ashington Innovations, Patricia Murray writes to the FCA

Patricia Murray of Liverpool has written to the FCA over both Ashington Innovations (ASHI) and Roquefort Therapeutics (ROQ). How a serious regulator can ignore what follows defies belief. Both companies are clearly utterly uninvestable. Ms Murray writes: 
RTOP
premium content

Letter to PKF LittleJohn – you will be reported to the FRC this weekend over dishonest IPO, marking your card

The auditors to Regtech Open (RTOP) which IPO’d on the Standard List on Friday is PKF Littlejohn where partner Joseph Baulf masterminded the transaction. I have written to Mr Baulf today to flag up his schoolboy errors and that I shall be reporting him and his firm to my good pals at the FRC later this bank holiday weekend.
Bear
premium content

A Bear Growls: Nine Bumper Reasons Why You Should Sell Rather Than Buy Just Now!

I note Malcolm Stacey’s column today on why you should buy now, in line with the old adage of sell in May and go away, come back on St. Leger’s Day. But I have to take issue with that, especially right now. I have immense respect for Malcolm – he was, after all, right all along in our early days: a lone bull in a wood full of bears. But on this occasion I really must beg to differ – as reader will know, the writers on this fine website are not paid to agree so here is why, in my view, that his nine cited reasons are wrong.
RST
premium content

Restore plc – recovery value playing out...

Describing itself as “the UK's leading provider of digital and information management and secure lifecycle services”, Restore plc (RST) recently announced results for the first half of the 2023 calendar year noting “a difficult period” but that “current trading remains in line with the board's revised expectations to achieve an adjusted profit before tax of £31m for the full year”. On HotStockRockets, we noted that we considered that suggested recovery value from a then 142p offer price of the shares just over a week ago. The shares are already now at 180p.
Bull

Nine Bumper Reasons Why you Should Buy Rather than Sell Just Now.

Hello Share Shunters. That old saw: Go away in May and come back on Leger Day has rarely worked in the past. But it’s been spot on this year. On the share markets we’ve had the most boring summer of all time. But will things change at the start of September when the classic race is held?
LIFS

LifeSafe Holdings – “pleased to announce” result of 'retail offer'. Hmmm, really?…

Fire safety products company LifeSafe Holdings (LIFS) states “further to the company's announcement dated 22 August… pleased to announce that, following the closing of the retail offer on the BookBuild platform on 25 August 2023, 315,090 ordinary shares will be issued at a price of 37 pence per retail offer share”. How ‘pleasing’ is this?
ZED
premium content

Zenova: a boastful fisherman wants you to say how clever he is after piss poor interims

The boastful fisherman in this case is Peter Brailey who has texted me repeatedly from the side of some dreary canal where he is spending the day boasting about how big a Roach he almost caught. Peter wants me to remind you about how on 6 October 2021 he warned you HERE that Zenova (ZED) was all hype and no substance. The market cap then was £18 million. Today, at 5p, it is just £4.8 million. But “who’s a clever boy then” warns it will get worse.
Bearcast
premium content

Tom Winnifrith Bearcast: 10 years is bloody amazing, the Mrs is a saint

I start with a weather report here at the Greek Hovel, will lightening strike twice? I end with what i regard as a miracle, given my track record, tonight the Mrs and I enjoy an early celebration of our tenth wedding anniversary. The woman is a saint. In between I look at Regtech Open (RTOP) and share with you a laughable document below, CMC Markets (CMCX), Guild ESports (GILD), and Versarien (VRS)
PRM
premium content

Proteome Sciences – interims argue “confident of maintaining the good performance”. Er, where was that then?

Describing itself as “a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification”, Proteome Sciences (PRM) has announced results for the first half of the 2023 calendar year including stating that it “is confident of maintaining the good performance into the second half of the year… cash resources of £3.79m (30 June 2022: £3.20m)”. So what of a current share price response down more than 25% at 6.3p?
JAY
premium content

BREAKING EXPOSE: BlueJay turned down far less dilutive finance ahead of bucket shop placing

When a company opts to dilute its own shareholders more than it needs to you know that management is running the enterprise for itself rather than the business owners and this is a terrible red flag. That brings us to BlueJay Mining (JAY) which, 7 weeks after raising £1.3 million at 1.7p, on 23 August raised just £600,000 at a penny. It did not need to as I today reveal.
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 08:11:12